If I were a pharmaceutical company who was not active in antibiotic research today, I would be making plans to be there tomorrow. A couple of companies that come to mind are Vertex and Gilead – especially Gilead.
Vertex has dabbled in antibiotic research in the past and finally gave up the ghost several years ago. Bad timing in my view – but, given their lack of productivity, maybe it was not the wrong decision at the time. Maybe now is the time to rethink.